Literature DB >> 12019885

Utility (or not) of Gd-DTPA-based dynamic MRI for breast cancer diagnosis and grading.

Timothy P L Roberts1, Thomas H Helbich, Sebastian Ley, Karl Turetschek, Michael F Wendland, David M Shames, Robert C Brasch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12019885     DOI： 10.1016/s1076-6332(03)80452-x

Source DB:  PubMed          Journal:  Acad Radiol        ISSN： 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  3 in total

1.  Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.

Authors:  Patrick M Winter; Anne H Schmieder; Shelton D Caruthers; Jeffery L Keene; Huiying Zhang; Samuel A Wickline; Gregory M Lanza
Journal:  FASEB J       Date:  2008-03-24       Impact factor: 5.191

2.  In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.

Authors:  Hans-Juergen Raatschen; Yanjun Fu; Robert C Brasch; Hubertus Pietsch; David M Shames; Benjamin M Yeh
Journal:  Invest Radiol       Date:  2009-05       Impact factor: 6.016

3.  Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.

Authors:  Hans-Juergen Raatschen; Gerhard H Simon; Yanjun Fu; Barbara Sennino; David M Shames; Michael F Wendland; Donald M McDonald; Robert C Brasch
Journal:  Radiology       Date:  2008-03-27       Impact factor: 11.105
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.